SMTI EBITDA Growth
Sanara Medtech Inc · EBITDA Growth
SMTI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported158.32%period ending
SMTI TTM EBITDA YoY % (-42.37% → 158.32%)
Year-over-year change
High-resolution chart · PNG
SMTI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 158.3223% | |
| 748.5107% | |
| 682.0198% | |
| 302.0089% | |
| 213.9232% | |
| 134.511% | |
| 61.7448% | |
| 16.1506% | |
| 51.521% | |
| 64.4019% | |
| 67.095% | |
| 62.8724% | |
| 39.3612% | |
| 13.6903% | |
| -35.9363% | |
| -136.9521% | |
| -167.2096% | |
| -131.8696% | |
| -59.2961% | |
| 8.8497% | |
| 16.5612% | |
| 4.9252% | |
| -77.8982% | |
| -219.4582% | |
| -379.2348% | |
| -526.6401% | |
| -506.3945% | |
| -701.8228% | |
| -349.6775% | |
| -234.9433% | |
| -188.1891% | |
| -47.4579% | |
| -44.7041% | |
| 273.1016% | |
| 331.0242% | |
| 159.2448% | |
| 160.2598% | |
| 66.9807% | |
| 80.8657% | |
| 8.1954% | |
| 16.726% | |
| 48.5127% | |
| 44.9653% | |
| 53.3763% | |
| 15.3783% | |
| -32.7963% | |
| -59.028% | |
| 47.7511% | |
| 67.1147% | |
| 76.5717% | |
| 71.6936% | |
| 52.9393% | |
| 26.8118% | |
| 27.9159% | |
| 62.7272% | |
| -36.3069% | |
| -13.2173% | |
| -20.8758% | |
| -340.7748% | |
| -155.3903% | |
| -251.8328% | |
| -289.3034% | |
| -57.3726% | |
| -36.8272% | |
| 3.5615% | |
| 13.8161% | |
| 1.2085% | |
| -57.9093% | |
| -124.0399% | |
| -210.1921% | |
| -352.4093% | |
| -227.626% | |
| -137.1651% | |
| -19.7102% | |
| 17.6989% | |
| 39.5857% | |
| 37.688% | |
| 35.9656% | |
| 43.947% | |
| 14.4954% | |
| 59.472% | |
| 28.2132% | |
| 15.4516% | |
| 45.17% | |
| -1.6448% | |
| 33.8721% | |
| -75.5083% | |
| -42.3654% |